Evaluate the Efficacy of Magnesium Isoglycyrrhizinate in the Prevention of Chemotherapy Related Acute Liver Injury

NCT01802996 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

2040

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasms
Liver Injury

Interventions

DRUG: Magnesium Isoglycyrrhizinate Injection

Sponsor

Cttq